BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$7.36

Market cap

$2.69B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.64

Enterprise value

$24.34B

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of ...

Highlights
Bausch Health Companies's quick ratio has increased by 12% YoY and by 10% from the previous quarter
The revenue has increased by 5% year-on-year and by 2.3% since the previous quarter
The company's equity has shrunk by 125% YoY and by 78% QoQ
The debt has increased by 9% since the previous quarter and by 6% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.bauschhealth.com
Peers: OGN

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
365.2M
Market cap
$2.69B
Enterprise value
$24.34B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.31
EV/EBIT
44.82
EV/EBITDA
13.24
EV/Sales
2.85
Earnings
Revenue
$8.54B
EBIT
$543M
EBITDA
$1.84B
Free cash flow
$893M
Per share
EPS
-$2.64
Free cash flow per share
$2.44
Book value per share
-$3.24
Revenue per share
$23.38
TBVPS
$25.04
Balance sheet
Total assets
$27.06B
Total liabilities
$27.3B
Debt
$22.43B
Equity
-$1.18B
Working capital
$824M
Liquidity
Debt to equity
-19.01
Current ratio
1.2
Quick ratio
0.65
Net debt/EBITDA
11.78
Margins
EBITDA margin
21.5%
Gross margin
70.7%
Net margin
-11.3%
Operating margin
4.3%
Efficiency
Return on assets
-3.7%
Return on equity
N/A
Return on invested capital
2.2%
Return on capital employed
2.4%
Return on sales
6.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
3.08%
1 week
6.2%
1 month
3.95%
1 year
-4.42%
YTD
17.2%
QTD
-10.46%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.54B
Gross profit
$6.04B
Operating income
$365M
Net income
-$963M
Gross margin
70.7%
Net margin
-11.3%
The operating margin has plunged by 67% YoY and by 39% from the previous quarter
The company's operating income has shrunk by 65% YoY and by 39% QoQ
The revenue has increased by 5% year-on-year and by 2.3% since the previous quarter
BHC's gross profit is up by 4.3% year-on-year and by 2.6% since the previous quarter

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.31
EV/EBIT
44.82
EV/EBITDA
13.24
EV/Sales
2.85
The company's equity has shrunk by 125% YoY and by 78% QoQ
The price to sales (P/S) is 61% lower than the 5-year quarterly average of 0.8 but 3.3% higher than the last 4 quarters average of 0.3
The revenue has increased by 5% year-on-year and by 2.3% since the previous quarter

Efficiency

How efficient is Bausch Health Companies business performance
BHC's return on sales has dropped by 70% year-on-year and by 60% since the previous quarter
BHC's return on invested capital has dropped by 68% year-on-year and by 60% since the previous quarter

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
The current ratio has grown by 14% YoY and by 7% from the previous quarter
Bausch Health Companies's quick ratio has increased by 12% YoY and by 10% from the previous quarter
The company's equity has shrunk by 125% YoY and by 78% QoQ
The debt to equity has surged by 53% year-on-year and by 39% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.